Physician profile
Vahik Meserkhani
NPI 1275784183
$234,516.31
in general payments reported to CMS, 2019-2025
12 companies · $44K in 2025
The $44K reported for 2025 was more than what 98% of Prosthodontics providers received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46K · 2020: $14K · 2021: $9,724 · 2022: $47K · 2023: $32K · 2024: $41K · 2025: $44K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $97K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $11K · Travel and Lodging: $5,918 · Food and Beverage: $3,562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $97,192.50 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $10,500.00 |
| Travel and Lodging | $5,917.88 |
| Food and Beverage | $3,561.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $163,367.19 | 2022-2025 | Tsx Implants |
| Zimmer Biomet Holdings, INC. | $69,258.25 | 2019-2021 | |
| Straumann USA LLC | $853.40 | 2020-2025 | |
| Implant Direct Sybron International LLC | $642.08 | 2021-2022 | |
| Geistlich Pharma, North America, INC. | $138.24 | 2019-2021 | |
| Nobel Biocare USA | $62.13 | 2023 | Nobelactive |
| Kulzer, LLC | $50.49 | 2019 | |
| 3m Company | $50.15 | 2021-2022 | |
| Philips North America LLC | $35.22 | 2019-2020 | |
| Biohorizons Implant Systems INC. | $24.00 | 2019 | |
| Kerr Corporation | $18.78 | 2019 | |
| Henry Schein, INC. | $16.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vahik Meserkhani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.